locationHilton Omaha1001 Cass Street, Omaha, Nebraska

rEgistration fEEThere is no fee to attend this educational activity. Pre-registration is required. Walk-in registrations will be accepted based on space availability.registration Deadline: January 30, 2009

cancEllation policyIf you registered and find that you will not be able to attend, please call (402) 559-5929 by Friday, January 30, 2009.

aDaIn compliance with the Americans with Disabilities Act, the UNMC Center for Continuing Education does not discriminate on the basis of disability. The Center shall provide reasonable accommodation, including auxiliary aids and services, to ensure equal access to its programs, services, and activities. If you would like an auxiliary aid or service, please call (402) 559-4152 by January 30, 2009 with your request.

parkingComplimentary parking is available in the hotel parking garage. Please be sure to identify yourself as an attendee of the UNMC Lymphoma Study Group dinner.

loDgingA block of rooms has been reserved at the Hilton Omaha at the special rate of $119 per room, per night for single/double occupancy for the night of Friday, February 6, 2009. Reservations can be made by calling (402) 998-3400 or 1-800-HILTONS. Please be sure to identify yourself with the UNMC Center for Continuing Education. The cut-off date for reservations is Friday, January 9, 2009. All reservations made after this date will be accepted on a space and rate availability basis.

for MorE inforMationContact Brenda Ram, CMP at (402) 559-9250 or email bram@unmc.edu.

Lymphoma Study GroupWinter 2009 Dinner Meeting

saVE tHE DatE:

Lymphoma Study Group

Spring 2009 Meeting

May 1, 2009

Please also plan to attend...2009 HEMatology HigHligHts:

a post asH rEViEWFebruary 7, 2009

Hilton Omaha

Topics and Speakers to include:• CML

Paul J. Shami, MD University of Utah - Huntsman Cancer Institute

• CLLWilliam G. Wierda, MD, PhD University of Texas - M. D. Anderson Cancer Center

• LymphomaPhilip J. Bierman, MD University of Nebraska Medical Center

• MultipleMyelomaIrene Ghobrial, MD Harvard Medical School - Dana Farber Cancer Institute

• MyelodysplasiaAzra Raza, MD St. Vincent’s Comprehensive Cancer Center

• AcuteLeukemiaHarry P. Erba, MD, PhDUniversity of Michigan Health System

• MPDsAnimesh Pardanani, MBBS, PhD Mayo Clinic

For further information, please contact Joan Husted at (402) 559-6235 or jhusted@unmc.edu. There is a $25 registration fee to attend this ASH Review.

Lymphoma Study GroupWinter 2009 Dinner Meeting

friday, february 6, 2009

HiltonOmaha1001 Cass Street Omaha, Nebraska

Please indicate your meal choice for Friday evening:

Roast Beef Tenderloin

Chicken

Vegetarian

rEgistration forM cik 9804

SSN (last four digits)

Name

Degree

Specialty

Mailing Address Home Work

City, State, ZIP

Telephone Number

Fax

Email Address

Nursing License Number State Issued

to rEgistEronlinEwww.unmc.edu/cceMailCenter for Continuing EducationUniversity of Nebraska Medical Center986800 Nebraska Medical CenterOmaha, NE 68198-6800

tElEpHonE*(402) 559-5929(877) 832-6924fax(402) 559-5915

rEgistration DEaDlinE: January 30, 2009

Lymphoma Study GroupWinter 2009 Dinner Meeting

friday, february 6, 2009

HiltonOmahaOmaha, Nebraska

*Available Monday through Friday from 9AM to 3PM CST

agEnDa

6:00 pm Registration/Refreshments& Hors d’oeuvres

6:30 pm Dinner

7:00 pm TreatmentofAcuteLymphoblasticLeukemiainAdults:ACaseBasedpresentationWendy Stock, MDProfessor of MedicineUniversity of Chicago Medical SchoolUniversity Cancer Research CenterChicago, Illinois

7:45 PM Questions and answers

8:00 PM adjourn

ABOuTTHesPeAkeR

Dr. Wendy Stock is an authority in the medical management of all types of leukemia and myelodysplastic syndromes. She collaborates with other oncologists around the world through the National Cancer Institute and the Cancer and Leukemia Group B to help identify and develop better approaches to chemotherapy and other cancer treatments.

Dr. Stock’s laboratory focuses on studies to determine the clinical significance of the molecular detection and monitoring of minimal residual disease (MRD) states following treatment for leukemia and lymphoma. The laboratory is a national reference laboratory for several of these studies. Dr. Stock is also developing novel technology to measure tyrosine kinase activity in leukemia cells as a method for predicting response to treatment with novel targeted kinase inhibitors.

She serves on the editorial board of the Journal of Clinical Oncology and has published papers and reviews in many esteemed medical journals. She has also spoken at international and national conferences on leukemia.

LeARNINGOBJeCTIVesAt the conclusion of this educational activity, the participant should be able to:

Present a brief overview of current treatment 1. outcomes in adult acute lymphoblastic leukemia. Review current treatment strategies for 2. biologically diverse subsets.Discuss challenges to future progress in 3. treatment of adult lymphoblastic leukemia.

crEDitThe University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.This activity is provided for 1.0 contact hours under ANCC criteria. Provided for 1.2 contact hours under Iowa Provider #78. Provider approved by the California Board of Registered Nursing, Provider #13699 for 1.2 contact hours.

Lymphoma Study GroupWinter 2009 Dinner Meeting